Department of Anesthesiology, Jiaxing Maternity and Child Care Hospital, Jiaxing, Zhejiang 314001, China.
Chin Med J (Engl). 2010 Jan 20;123(2):178-83.
Ropivacaine and levobupivacaine have been introduced into obstetric analgesic practice with the proposed advantages of causing less motor block and toxicity compared with bupivacaine. However, it is still controversial whether both anesthetics are associated with any clinical benefit relative to bupivacaine for labor analgesia. This study aimed to compare the analgesic efficacy, motor block and side effects of bupivacaine, ropivacaine and levobupivacaine at lower concentrations for patient-controlled epidural labor analgesia.
Four hundred and fifty nulliparous parturients were enrolled in this randomized clinical trial. A concentration of 0.05%, 0.075%, 0.1%, 0.125% or 0.15% of either bupivacaine (Group B), ropivacaine (Group R) or levobupivacaine (Group L) with sufentanil 0.5 microg/ml was epidurally administered by patient-controlled analgesia mode. Effective analgesia was defined as a visual analogue scale score was <or=30 mm. The relative median potency for each local anesthetic was calculated using a probit regression model. Parturients demographics, sensory and motor blockade, obstetric data, maternal side effects, hourly volumes of local anesthetic used, and others were also noted.
There were no significant differences among groups in the numbers of effective analgesia, pain scores, hourly local anesthetic amount used, sensory and motor blockade, labor duration and mode of delivery, side effects and maternal satisfaction (P>0.05). The relative median potency was bupivacaine/ropivacaine: 0.828 (0.602-1.091), bupivacaine/levobupivacaine: 0.845 (0.617-1.12), ropivacaine/levobupivacaine: 1.021 (0.774-1.354), respectively. However, a significantly less number of effective analgesia and higher hourly local anesthetic use were observed in the concentration of 0.05% than those of >or=0.1% within each group (P<0.05).
Using patient-controlled epidural analgesia, lower concentrations of bupivacaine, ropivacaine and levobupivacaine with sufentanil produce similar analgesia and motor block and safety for labor analgesia. The analgesic efficacy mainly depends on the concentration rather than the type of anesthetics.
罗哌卡因和左旋布比卡因已被引入产科镇痛实践中,与布比卡因相比,它们具有引起运动阻滞和毒性较小的优点。然而,对于分娩镇痛,这两种麻醉剂是否与布比卡因相比具有任何临床优势仍存在争议。本研究旨在比较布比卡因、罗哌卡因和左旋布比卡因在较低浓度下用于患者自控硬膜外分娩镇痛的镇痛效果、运动阻滞和副作用。
本研究纳入了 450 名初产妇,采用随机临床试验设计。在患者自控镇痛模式下,布比卡因(B 组)、罗哌卡因(R 组)或左旋布比卡因(L 组)的浓度分别为 0.05%、0.075%、0.1%、0.125%或 0.15%,同时联合舒芬太尼 0.5μg/ml。有效镇痛定义为视觉模拟评分(VAS)<或=30mm。采用概率单位回归模型计算每种局部麻醉剂的相对中效浓度。记录产妇的人口统计学资料、感觉和运动阻滞、产科数据、产妇副作用、每小时局部麻醉剂用量等。
各组间有效镇痛的次数、疼痛评分、每小时局部麻醉剂用量、感觉和运动阻滞、产程和分娩方式、副作用和产妇满意度均无统计学差异(P>0.05)。相对中效浓度为布比卡因/罗哌卡因:0.828(0.602-1.091),布比卡因/左旋布比卡因:0.845(0.617-1.12),罗哌卡因/左旋布比卡因:1.021(0.774-1.354)。然而,与各浓度组>或=0.1%相比,0.05%浓度组的有效镇痛次数和每小时局部麻醉剂用量明显减少(P<0.05)。
使用患者自控硬膜外镇痛,舒芬太尼联合布比卡因、罗哌卡因和左旋布比卡因的较低浓度可产生相似的镇痛和运动阻滞效果,且用于分娩镇痛安全。镇痛效果主要取决于浓度,而不是麻醉剂的类型。